Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male reproductive...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Determination of fermentable sugars in beer wort by gold nanoparticles@polydopamine: A layer-by-layer approach for Localized Surface Plasmon Resonance measurements at fixed wavelength.

Talanta·2018
Same author

Structural characterization of magnesium silicate hydrate: towards the design of eco-sustainable cements.

Dalton transactions (Cambridge, England : 2003)·2016
Same author

Glioblastoma stem cells: radiobiological response to ionising radiations of different qualities.

Radiation protection dosimetry·2015
Same author

Low-radiation environment affects the development of protection mechanisms in V79 cells.

Radiation and environmental biophysics·2015
Same author

Quantum Monte Carlo study of a resonant Bose-Fermi mixture.

Physical review letters·2014
Same author

Physicochemical characterization of partially hydrolyzed poly(vinyl acetate)-borate aqueous dispersions.

Soft matter·2014

Related Experiment Video

Updated: Jun 25, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Spermine metabolism and anticancer therapy.

R Amendola1, M Cervelli, E Fratini

  • 1ENEA, CR Casaccia, BAS-BIOTEC MED, Rome, Italy. amendola@casaccia.enea.it

Current Cancer Drug Targets
|March 12, 2009
PubMed
Summary

Polyamines (PA) like spermine (SPM) are crucial in cell growth. Targeting SPM metabolism via spermine oxidase (SMO) offers a novel cancer therapy strategy by inducing oxidative stress and inhibiting proliferation.

Related Experiment Videos

Last Updated: Jun 25, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Natural polyamines (putrescine, spermidine, spermine) are vital in eukaryotic cells.
  • Elevated polyamine levels correlate with malignant and proliferating cells, suggesting polyamine depletion as a cancer therapy strategy.
  • While targeting polyamine metabolism is complex, spermine oxidase (SMO) is a key enzyme for spermine (SPM) catabolism.

Purpose of the Study:

  • To explore the therapeutic potential of targeting spermine metabolism in cancer treatment.
  • To investigate the role of spermine oxidase (SMO) in polyamine homeostasis and its implications for cell growth and differentiation.
  • To evaluate SPM analogues as potential anticancer agents.

Main Methods:

  • Review of scientific literature on polyamine metabolism and spermine oxidase.
  • Analysis of the effects of SMO activity on cellular oxidative stress and cell death.
  • Examination of the cytotoxic effects of extracellular SPM and its analogues.

Main Results:

  • Augmented SMO activity induces oxidative stress, leading to cell death and influencing cell differentiation.
  • Extracellular SPM is cytotoxic, while its analogues can inhibit cell growth by depleting intracellular SPM.
  • Altering SPM metabolism presents a multi-faceted therapeutic strategy beyond simple polyamine inhibition.

Conclusions:

  • Targeting SPM metabolism, particularly through SMO, offers a promising avenue for novel cancer therapeutics.
  • SPM-related therapeutic approaches may benefit composite treatment protocols for cancer.
  • Further clinical trials are needed to establish the efficacy of tetramine-based therapies in cancer treatment.